Current and Future Developments of Predictive Markers and Prognostic Testing in IBD
IL-12/23 and IL-23 Receptor Antagonists
Sara Horst, MD, MPH
Small Molecules (JAKi/S1P agonists)
Kara DeFelice, MD
IBD Immunology and Emerging Therapies: Where Are We and Where We Are Going
Matthew Ciorba, MD
2022 Crohn's & Colitis Congress
Loading...
We’re glad to see you’re enjoying Crohn's Colitis Professional…but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.